-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
16,075 Shares in Actuate Therapeutics (NASDAQ:ACTU) Purchased by Sigma Planning Corp
Sigma Planning Corp bought a new position in shares of Actuate Therapeutics (NASDAQ:ACTU – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 16,075 shares of the company’s stock, valued at approximately $128,000. Sigma Planning Corp owned approximately 0.08% […]
Sigma Planning Corp bought a new position in shares of Actuate Therapeutics (NASDAQ:ACTU – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 16,075 shares of the company’s stock, valued at approximately $128,000. Sigma Planning Corp owned approximately 0.08% […]
